To include your compound in the COVID-19 Resource Center, submit it here.

ANI Pharmaceuticals, BioSante deal

BioSante adjourned its stockholders meeting until April 12 to give stockholders additional time to

Read the full 147 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE